Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 · Hepatology · 10K citations
https://doi.org/10.1002/hep.20701
D
David E. Kleiner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.0K
Papers
87.7K
Citations
132
h-index
488
i10-index
David E. Kleiner is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatitis C virus research & Hepatitis B Virus Studies. The author has an h-index of 132, co-authored 882 publications.
ORCID: 0000-0003-3442-4453Papers by this author
worksPioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 · New England Journal of Medicine · 3,223 citations
https://doi.org/10.1056/nejmoa0907929
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
2020 · Gastroenterology · 3,178 citations
https://doi.org/10.1053/j.gastro.2019.11.312
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
2015 · Gastroenterology · 2,851 citations
https://doi.org/10.1053/j.gastro.2015.04.043
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 · Hepatology · 1,958 citations
https://doi.org/10.1097/hep.0000000000000323
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
2021 · New England Journal of Medicine · 986 citations
https://doi.org/10.1056/nejmoa2029349
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat